Technical Analysis for CPHRF - Cipher Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade D 0.9979 6.16% 0.0579
CPHRF closed up 6.16 percent on Friday, January 17, 2020, on 1.38 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical CPHRF trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 6.16%
Wide Bands Range Expansion 6.16%
Overbought Stochastic Strength 6.16%
Gapped Down Weakness 6.16%
1,2,3 Retracement Bearish Bearish Swing Setup 5.25%
Older signals for CPHRF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Medicine RTT Organ Systems Psoriasis Rheumatoid Arthritis Acne Dermatology Cutaneous Conditions Anti Acne Preparations Plaque Psoriasis Actinic Keratosis High Cholesterol Keratosis

Is CPHRF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.405
52 Week Low 0.6667
Average Volume 5,797
200-Day Moving Average 1.9341
50-Day Moving Average 0.9217
20-Day Moving Average 0.8461
10-Day Moving Average 0.8133
Average True Range 0.0504
ADX 26.84
+DI 45.0384
-DI 39.6218
Chandelier Exit (Long, 3 ATRs ) 0.8467
Chandelier Exit (Short, 3 ATRs ) 0.8179
Upper Bollinger Band 1.0446
Lower Bollinger Band 0.6476
Percent B (%b) 0.88
BandWidth 46.9212
MACD Line -0.0078
MACD Signal Line -0.0372
MACD Histogram 0.0293
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.9979
Resistance 3 (R3) 0.9979 0.9979 0.9979
Resistance 2 (R2) 0.9979 0.9979 0.9979 0.9979
Resistance 1 (R1) 0.9979 0.9979 0.9979 0.9979 0.9979
Pivot Point 0.9979 0.9979 0.9979 0.9979 0.9979
Support 1 (S1) 0.9979 0.9979 0.9979 0.9979 0.9979
Support 2 (S2) 0.9979 0.9979 0.9979 0.9979
Support 3 (S3) 0.9979 0.9979 0.9979
Support 4 (S4) 0.9979